Authors
Loading...
This study reveals differences in diagnosis-to-treatment intervals for early-stage ER+ breast cancer in public and private health care settings.
Barroso‐Sousa et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: